Your browser doesn't support javascript.
loading
miRNAs, Mesenchymal Stromal Cells and Major Neoplastic and Inflammatory Skin Diseases: A Page Being Written: A Systematic Review.
Di Vincenzo, Mariangela; Diotallevi, Federico; Piccirillo, Silvia; Carnevale, Gianluca; Offidani, Annamaria; Campanati, Anna; Orciani, Monia.
Afiliación
  • Di Vincenzo M; Department of Clinical and Molecular Sciences-Histology, Università Politecnica delle Marche, 60126 Ancona, Italy.
  • Diotallevi F; Department of Clinical and Molecular Sciences-Dermatological Clinic, Università Politecnica delle Marche, 60126 Ancona, Italy.
  • Piccirillo S; Department of Biomedical Sciences and Public Health-Pharmacology, Università Politecnica delle Marche, 60126 Ancona, Italy.
  • Carnevale G; Department of Surgery, Medicine, Dentistry and Morphological Sciences with Interest in Transplant, Oncology and Regenerative Medicine, Università di Modena e Reggio Emilia, 41121 Modena, Italy.
  • Offidani A; Department of Clinical and Molecular Sciences-Dermatological Clinic, Università Politecnica delle Marche, 60126 Ancona, Italy.
  • Campanati A; Department of Clinical and Molecular Sciences-Dermatological Clinic, Università Politecnica delle Marche, 60126 Ancona, Italy.
  • Orciani M; Department of Clinical and Molecular Sciences-Histology, Università Politecnica delle Marche, 60126 Ancona, Italy.
Int J Mol Sci ; 24(10)2023 May 09.
Article en En | MEDLINE | ID: mdl-37239847
ABSTRACT
Micro RNAs (miRNAs) are a type of non-coding RNA (ncRNA) and typically interact with specific target mRNAs through complementary base pairing, affecting their translation and/or stability. MiRNAs regulate nearly all cellular functions, including the cell fate of mesenchymal stromal cells (MSCs). It is now accepted that various pathologies arise at the stem level, and, in this scenario, the role played by miRNAs in the fate of MSCs becomes of primary concern. Here we have considered the existing literature in the field of miRNAs, MSCs and skin diseases, classified as inflammatory (such as psoriasis and atopic dermatitis-AD) and neoplastic (melanoma and non-melanoma-skin-cancer including squamous cell and basal cell carcinoma) diseases. In this scoping review article, the evidence recovered indicates that this topic has attracted attention, but it is still a matter of opinion. A protocol for this review was registered in PROSPERO with the registration number "CRD42023420245". According to the different skin disorders and to the specific cellular mechanisms considered (cancer stem cells, extracellular vesicles, inflammation), miRNAs may play a pro- or anti-inflammatory, as well as a tumor suppressive, or supporting, role, indicating a complex regulation of their function. It is evident that the mode of action of miRNAs is more than a switch on-off, and all the observed effects of their dysregulated expression must be checked in a detailed analysis of the targeted proteins. The involvement of miRNAs has been studied mainly for squamous cell carcinoma and melanoma, and much less in psoriasis and AD; different mechanisms have been considered, such as miRNAs included in extracellular vesicles derived both from MSCs or tumor cells, miRNAs involved in cancer stem cells formation, up to miRNAs as candidates to be new therapeutic tools.
Asunto(s)
Palabras clave

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Psoriasis / Enfermedades de la Piel / MicroARNs / Células Madre Mesenquimatosas / Neoplasias Tipo de estudio: Guideline / Systematic_reviews Límite: Humans Idioma: En Revista: Int J Mol Sci Año: 2023 Tipo del documento: Article País de afiliación: Italia

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Psoriasis / Enfermedades de la Piel / MicroARNs / Células Madre Mesenquimatosas / Neoplasias Tipo de estudio: Guideline / Systematic_reviews Límite: Humans Idioma: En Revista: Int J Mol Sci Año: 2023 Tipo del documento: Article País de afiliación: Italia
...